Phase II Study of RC1416 Injection in COPD

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Study of RC1416 Injection in COPD	Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)	Recruiting	Phase 2	2026-09-08		NCT07402551

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nanjing RegeneCore Biotech Co., Ltd.	3

46 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Zunyi Medical University	Zunyi	China	17
Anhui Provincial Chest Hospital	Hefei	China	1
Anyang People's Hospital	Anyang	China	6
Chengdu Fifth People's Hospital	Chengdu	China	9
Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital)	Qingyuan	China	1
Huizhou Third People's Hospital	Huizhou	China	2
Jiangmen Central Hospital	Jiangmen	China	18
Jiaozuo Second People's Hospital	Jiaozuo	China	1
Jiu Jiang NO.1 People's Hospital	Jiujiang	China	1
Liaocheng People's Hospital	Liaocheng	China	20
Loudi Central Hospital	Loudi	China	3
Mianyang Central Hospital	Mianyang	China	7
Nanjing First Hospital	Nanjing	China	47
Nanyang First People's Hospital	Nanyang	China	3
Nanyang Second People's Hospital	Nanyang	China	1
People's Hospital of Pingxiang City	Pingxiang	China	1
Qingdao Municipal Hospital	Qingdao	China	7
Sanmenxia Central Hospital	Sanmenxia	China	8
Shanghai Pulmonary Hospital	Shanghai	China	72
Shengjing Hospital Of China Medical University	Shenyang	China	54
Suining Central Hospital	Suining	China	15
Suining County People's Hospital	Xuzhou	China	1
The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU	Wenzhou	China	1
The Affiliated Bishan Hospital of Chongqing Medical University	Chongqing	China	1
The Affiliated Hospital of Inner Mongolia Medical University	Hohhot	China	4

Clinical trials